New Resveratrol Derivatives Exhibit Acetylcholinesterase Inhibitory Properties and Decrease Reactive Oxygen Species Production in the SH-SY5Y Human Neuroblastoma Cell Line

Alzheimer’s disease (AD) is a multifactorial neurodegenerative disorder. Acetylcholinesterase (AChE) inhibitors constitute a pharmacotherapeutic strategy for AD treatment. Resveratrol has anti-inflammatory, neuroprotective, anticarcinogenic, and antioxidant properties. This study aimed to evaluate t...

Full description

Bibliographic Details
Main Authors: Martina Donozo, Valeria Cavallaro, Carlos Javier Baier, Ana Paula Murray
Format: Article
Language:English
Published: MDPI AG 2023-03-01
Series:Medical Sciences Forum
Subjects:
Online Access:https://www.mdpi.com/2673-9992/21/1/31
_version_ 1797379880272265216
author Martina Donozo
Valeria Cavallaro
Carlos Javier Baier
Ana Paula Murray
author_facet Martina Donozo
Valeria Cavallaro
Carlos Javier Baier
Ana Paula Murray
author_sort Martina Donozo
collection DOAJ
description Alzheimer’s disease (AD) is a multifactorial neurodegenerative disorder. Acetylcholinesterase (AChE) inhibitors constitute a pharmacotherapeutic strategy for AD treatment. Resveratrol has anti-inflammatory, neuroprotective, anticarcinogenic, and antioxidant properties. This study aimed to evaluate the AChE inhibitory properties and the protective role against oxidative stress damage of five resveratrol analogs (M1 to M5) in SH-SY5Y cells. The studied compounds were not cytotoxic in a wide range of concentrations. The treatment of SH-SY5Y cells at the AChE’s IC50s concentration significantly decreased the AChE enzyme activity in live cells. Through the dichlorofluorescein (DCF) assay, three compounds decreased the endogenous production of reactive oxygen species (ROS). These results demonstrate that, in addition to their action as biologically active AChE inhibitors, some resveratrol derivatives exhibit neuroprotective effects against endogenous ROS production.
first_indexed 2024-03-08T20:29:27Z
format Article
id doaj.art-ddbe52d6d4874bc5be4afebb3c88bbb2
institution Directory Open Access Journal
issn 2673-9992
language English
last_indexed 2024-03-08T20:29:27Z
publishDate 2023-03-01
publisher MDPI AG
record_format Article
series Medical Sciences Forum
spelling doaj.art-ddbe52d6d4874bc5be4afebb3c88bbb22023-12-22T14:28:44ZengMDPI AGMedical Sciences Forum2673-99922023-03-012113110.3390/ECB2023-14094New Resveratrol Derivatives Exhibit Acetylcholinesterase Inhibitory Properties and Decrease Reactive Oxygen Species Production in the SH-SY5Y Human Neuroblastoma Cell LineMartina Donozo0Valeria Cavallaro1Carlos Javier Baier2Ana Paula Murray3Instituto de Química del Sur (INQUISUR-CONICET-UNS), Departamento de Química, Universidad Nacional del Sur, Av. Alem 1253, Bahía Blanca 8000, ArgentinaInstituto de Química del Sur (INQUISUR-CONICET-UNS), Departamento de Química, Universidad Nacional del Sur, Av. Alem 1253, Bahía Blanca 8000, ArgentinaLaboratorio de Toxicología, Instituto de Ciencias Biológicas y Biomédicas del Sur (INBIOSUR-CONICET-UNS), Departamento de Biología, Bioquímica y Farmacia (DBByF), Universidad Nacional del Sur, San Juan 670, Bahía Blanca 8000, ArgentinaInstituto de Química del Sur (INQUISUR-CONICET-UNS), Departamento de Química, Universidad Nacional del Sur, Av. Alem 1253, Bahía Blanca 8000, ArgentinaAlzheimer’s disease (AD) is a multifactorial neurodegenerative disorder. Acetylcholinesterase (AChE) inhibitors constitute a pharmacotherapeutic strategy for AD treatment. Resveratrol has anti-inflammatory, neuroprotective, anticarcinogenic, and antioxidant properties. This study aimed to evaluate the AChE inhibitory properties and the protective role against oxidative stress damage of five resveratrol analogs (M1 to M5) in SH-SY5Y cells. The studied compounds were not cytotoxic in a wide range of concentrations. The treatment of SH-SY5Y cells at the AChE’s IC50s concentration significantly decreased the AChE enzyme activity in live cells. Through the dichlorofluorescein (DCF) assay, three compounds decreased the endogenous production of reactive oxygen species (ROS). These results demonstrate that, in addition to their action as biologically active AChE inhibitors, some resveratrol derivatives exhibit neuroprotective effects against endogenous ROS production.https://www.mdpi.com/2673-9992/21/1/31resveratrolAlzheimer’s diseaseacetylcholinesteraseSH-SY5Y cellsreactive oxygen species
spellingShingle Martina Donozo
Valeria Cavallaro
Carlos Javier Baier
Ana Paula Murray
New Resveratrol Derivatives Exhibit Acetylcholinesterase Inhibitory Properties and Decrease Reactive Oxygen Species Production in the SH-SY5Y Human Neuroblastoma Cell Line
Medical Sciences Forum
resveratrol
Alzheimer’s disease
acetylcholinesterase
SH-SY5Y cells
reactive oxygen species
title New Resveratrol Derivatives Exhibit Acetylcholinesterase Inhibitory Properties and Decrease Reactive Oxygen Species Production in the SH-SY5Y Human Neuroblastoma Cell Line
title_full New Resveratrol Derivatives Exhibit Acetylcholinesterase Inhibitory Properties and Decrease Reactive Oxygen Species Production in the SH-SY5Y Human Neuroblastoma Cell Line
title_fullStr New Resveratrol Derivatives Exhibit Acetylcholinesterase Inhibitory Properties and Decrease Reactive Oxygen Species Production in the SH-SY5Y Human Neuroblastoma Cell Line
title_full_unstemmed New Resveratrol Derivatives Exhibit Acetylcholinesterase Inhibitory Properties and Decrease Reactive Oxygen Species Production in the SH-SY5Y Human Neuroblastoma Cell Line
title_short New Resveratrol Derivatives Exhibit Acetylcholinesterase Inhibitory Properties and Decrease Reactive Oxygen Species Production in the SH-SY5Y Human Neuroblastoma Cell Line
title_sort new resveratrol derivatives exhibit acetylcholinesterase inhibitory properties and decrease reactive oxygen species production in the sh sy5y human neuroblastoma cell line
topic resveratrol
Alzheimer’s disease
acetylcholinesterase
SH-SY5Y cells
reactive oxygen species
url https://www.mdpi.com/2673-9992/21/1/31
work_keys_str_mv AT martinadonozo newresveratrolderivativesexhibitacetylcholinesteraseinhibitorypropertiesanddecreasereactiveoxygenspeciesproductionintheshsy5yhumanneuroblastomacellline
AT valeriacavallaro newresveratrolderivativesexhibitacetylcholinesteraseinhibitorypropertiesanddecreasereactiveoxygenspeciesproductionintheshsy5yhumanneuroblastomacellline
AT carlosjavierbaier newresveratrolderivativesexhibitacetylcholinesteraseinhibitorypropertiesanddecreasereactiveoxygenspeciesproductionintheshsy5yhumanneuroblastomacellline
AT anapaulamurray newresveratrolderivativesexhibitacetylcholinesteraseinhibitorypropertiesanddecreasereactiveoxygenspeciesproductionintheshsy5yhumanneuroblastomacellline